Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Fresenius Kabi And Formycon Ally On Stelara Rival
German Firms Strike Global Licensing Agreement For FYB202 Ustekinumab Biosimilar
Feb 02 2023
•
By
David Wallace
Formycon and Fresenius have struck a deal on FYB202 • Source: Shutterstock
More from Deals
More from Business